Oral Cavity Cancer
38
12
15
15
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.3%
2 terminated out of 38 trials
88.2%
+1.7% vs benchmark
5%
2 trials in Phase 3/4
7%
1 of 15 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 15 completed trials
Clinical Trials (38)
Integrated Cancer Repository for Cancer Research
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)
Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery
Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
The ENHANCE Study: Exercise and Nutrition in Head And Neck CancEr Survivors
Pembrolizumab in Combination With CRT for LA-SCCHN
Evaluation of the Benefit of a New Surgical Procedure According to IDEAL Recommendations for ORL Cancer Patients: the External Pudendal Flap Used as a New Free Flap for Oral Cavity/Oropharyngeal Reconstruction to Limit Donor Site Sequelae
Mandibular Reconstruction Preplanning (ViPMR)
Radiotherapy of Head and Neck Cancer Using an Intraoral Stent
Radial Forearm Donor Site Closure
Gross Examinations Versus Frozen Section for Assessment of Surgical Margins in Oral Cancers
Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL
Predictive Tools in Head and Neck Cancer Patients Undergoing Radiotherapy
Risk Factors Contributing to Oral Cancer in Patients at Dr. Hasan Sadikin General Hospital Bandung
Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis
Dysphagia and Quality of Life in Patients With Oral Squamous Cell Carcinoma Before and After Treatment